Search details
1.
Extracellular vesicles promote migration despite BRAF inhibitor treatment in malignant melanoma cells.
Cell Commun Signal
; 22(1): 282, 2024 May 22.
Article
in English
| MEDLINE | ID: mdl-38778340
2.
Comparison of surgical strategies in the treatment of low-risk differentiated thyroid cancer.
BMC Endocr Disord
; 23(1): 23, 2023 Jan 26.
Article
in English
| MEDLINE | ID: mdl-36703169
3.
High Tumor-Infiltrating Lymphocyte Count Is Associated with Distinct Gene Expression Profile and Longer Patient Survival in Advanced Ovarian Cancer.
Int J Mol Sci
; 24(18)2023 Sep 05.
Article
in English
| MEDLINE | ID: mdl-37761986
4.
Impact of a Targeted Project for Shortening of Imaging Diagnostic Waiting Time in Patients with Suspected Oncological Diseases in Hungary.
Medicina (Kaunas)
; 59(1)2023 Jan 12.
Article
in English
| MEDLINE | ID: mdl-36676777
5.
Platelet glycoprotein VI promotes metastasis through interaction with cancer cell-derived galectin-3.
Blood
; 135(14): 1146-1160, 2020 04 02.
Article
in English
| MEDLINE | ID: mdl-32040544
6.
Methyl Donors Reduce Cell Proliferation by Diminishing Erk-Signaling and NFkB Levels, While Increasing E-Cadherin Expression in Panc-1 Cell Line.
Int J Mol Sci
; 23(5)2022 Feb 25.
Article
in English
| MEDLINE | ID: mdl-35269689
7.
A Liquid Biopsy-Based Approach for Monitoring Treatment Response in Post-Operative Colorectal Cancer Patients.
Int J Mol Sci
; 23(7)2022 Mar 29.
Article
in English
| MEDLINE | ID: mdl-35409133
8.
Co-occurrence of thyroid and breast cancer is associated with an increased oncogenic SNP burden.
BMC Cancer
; 21(1): 706, 2021 Jun 15.
Article
in English
| MEDLINE | ID: mdl-34130653
9.
Methyl-Donors Can Induce Apoptosis and Attenuate Both the Akt and the Erk1/2 Mediated Proliferation Pathways in Breast and Lung Cancer Cell Lines.
Int J Mol Sci
; 22(7)2021 Mar 30.
Article
in English
| MEDLINE | ID: mdl-33808426
10.
Comparison of different motion correction techniques for dynamic FDG-PET/CT studies in breast cancer patients.
Q J Nucl Med Mol Imaging
; 64(4): 406-413, 2020 Dec.
Article
in English
| MEDLINE | ID: mdl-30792380
11.
Neoadjuvant PF-05280014 (a potential trastuzumab biosimilar) versus trastuzumab for operable HER2+ breast cancer.
Br J Cancer
; 119(3): 266-273, 2018 08.
Article
in English
| MEDLINE | ID: mdl-30002437
12.
[Chemobrain]. / Chemobrain.
Neuropsychopharmacol Hung
; 20(3): 112-116, 2018 Sep.
Article
in Hungarian
| MEDLINE | ID: mdl-30459288
13.
[In vivo analysis of circulating cell-free DNA release and degradation]. / A sejten kívüli szabad DNS felszabadulásának és degradációjának in vivo elemzése.
Orv Hetil
; 159(6): 223-233, 2018 Feb.
Article
in Hungarian
| MEDLINE | ID: mdl-29400102
14.
[Systemic treatment options of primary hepatocellular carcinoma]. / A primer májdaganat gyógyszeres kezelési lehetõségei.
Magy Onkol
; 62(1): 53-61, 2018 Mar 23.
Article
in Hungarian
| MEDLINE | ID: mdl-29570187
15.
[Experience with cabazitaxel therapy for patients with metastatic castrate resistant prostate cancer in Hungary]. / Hazai tapasztalatok kasztrációrezisztens metasztatikus prosztatadaganatos betegek kabazitaxelterápiájával.
Magy Onkol
; 61(4): 353-360, 2017 Dec 18.
Article
in Hungarian
| MEDLINE | ID: mdl-29257155
16.
PREDICTIVE VALUE OF SOMATIC MUTATIONS FOR THE DEVELOPMENT OF MALIGNANCY IN THYROID NODULES BY CYTOPATHOLOGY.
Endocr Pract
; 22(9): 1081-7, 2016 Sep.
Article
in English
| MEDLINE | ID: mdl-27214302
17.
Morphological and pathological response in primary systemic therapy of patients with breast cancer and the prediction of disease free survival: a single center observational study.
Croat Med J
; 57(2): 131-9, 2016 Apr 23.
Article
in English
| MEDLINE | ID: mdl-27106355
18.
[Immunotherapy opportunities in breast cancer]. / Új immunterápiás lehetõségek az emlõrák kezelésében.
Magy Onkol
; 60(1): 34-40, 2016 03 02.
Article
in Hungarian
| MEDLINE | ID: mdl-26934349
19.
[Systemic therapy of breast cancer: practice guideline]. / Az emlõrák szisztémás kezelése: szakmai útmutatás.
Magy Onkol
; 60(3): 241-57, 2016 09.
Article
in Hungarian
| MEDLINE | ID: mdl-27579723
20.
Response evaluation after primary systemic therapy of Her2 positive breast cancer an observational cross-sectional study.
Croat Med J
; 56(2): 128-38, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25891872